![N-[3-([5,5'-Bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)benzamide](https://static.cymitquimica.com/products/3D/img/FB103637.png "Cliccare per ingrandire")
N-[3-([5,5'-Bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)benzamide
CAS: 887650-05-7
Rif. 3D-FB103637
| 5mg | Prezzo su richiesta | |
| 10mg | Prezzo su richiesta | |
| 25mg | Prezzo su richiesta |
Informazioni sul prodotto
- N-{3-[([5,5'-bipyrimidin]-2-yl)amino]-4-methylphenyl}-4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzamide
N-[3-([5,5'-Bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)benzamide is a drug that inhibits the tyrosine kinase receptor and is used in the treatment of chronic myeloid leukaemia. It has been shown to inhibit osteoclast formation and bone resorption by inhibiting the action of phosphatidylserine receptors on osteoclasts. This drug has also been shown to be effective against multidrug resistant cancer cells. Bafetinib has been shown to inhibit bcr-abl kinase and is used in the treatment of acute lymphoblastic leukemia.
Proprietà chimiche
Richiesta tecnica su: 3D-FB103637 N-[3-([5,5'-Bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)benzamide
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
